Diagnosis and treatment of tuberous sclerosis
CA 2495085 A1 · Owner: Guan, Kun-Liang · Inventors: Guan, Kun-Liang
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compositions and methods for identifying abnormalities in TSC signaling pathways. In particular the present invention , relates to methods of diagnosing and treating disorders such as tuberous sclerosis, which are caused by mutations in the TSC genes. The present invention further relates to methods and compositions for treating cancers mediated by TSC signaling disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 12, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 12, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 12, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.